Literature DB >> 12745075

Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.

Chau-Ting Yeh1, Su-Chuan Lu, Chung-Hao Chao, Mei-Ling Chao.   

Abstract

The cyclin-dependent kinase (Cdk)-associated protein phosphatase (KAP) is a human dual-specificity protein phosphatase that dephosphorylates Cdk2 on a conserved threonine residue, T160, in a cyclin dependent manner. Several aberrant KAP transcripts with characteristic deletion regions have been identified in hepatocellular carcinoma tissues. In this report, we demonstrated that multiple aberrant KAP transcripts were also present in a hepatoblastoma cell line (HepG2), albeit harboring a totally different set of deletions. By performing yeast two-hybrid and co-immunoprecipitation experiments, a KAP-Cdk2 interaction domain located in the amino acid 1-34 region was identified. This interaction domain was different from the major protein interface deduced from crystal structure analysis. Using a yeast three-hybrid system, it was shown that the presence of a truncated KAP mutant encoding this interaction domain abolished the wild-type KAP-Cdk2 interaction. In conclusion, a previously unidentified KAP-Cdk2 interaction domain was discovered. Truncated KAP mutants containing this domain interfered with the wild-type KAP-Cdk2 interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745075     DOI: 10.1016/s0006-291x(03)00757-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells.

Authors:  Maria Cekanova; Joshua S Yuan; Xiuoon Li; Kyubo Kim; Seung Joon Baek
Journal:  Int J Oncol       Date:  2008-04       Impact factor: 5.650

2.  CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.

Authors:  Hanxu Yu; Jun Yao; Mingyu Du; Jinjun Ye; Xia He; Li Yin
Journal:  Oncol Lett       Date:  2019-11-11       Impact factor: 2.967

3.  Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.

Authors:  Wey-Ran Lin; Ming-Wei Lai; Chau-Ting Yeh
Journal:  Oncol Rep       Date:  2012-12-24       Impact factor: 3.906

4.  Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.

Authors:  Xiao Zang; Min Chen; Yunyun Zhou; Guanghua Xiao; Yang Xie; Xinlei Wang
Journal:  Cancer Inform       Date:  2015-05-24

5.  CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.

Authors:  Eira Valeria Barrón; Edgar Roman-Bassaure; Ana Laura Sánchez-Sandoval; Ana María Espinosa; Mariano Guardado-Estrada; Ingrid Medina; Eligia Juárez; Ana Alfaro; Miriam Bermúdez; Rubén Zamora; Carlos García-Ruiz; Juan Carlos Gomora; Susana Kofman; E Martha Pérez-Armendariz; Jaime Berumen
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

6.  A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.

Authors:  Qinghuang Chen; Ke Chen; Guijie Guo; Fang Li; Chao Chen; Song Wang; Grzegorz Nalepa; Shile Huang; Ji-Long Chen
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

7.  Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Authors:  Zofia Wotschofsky; Linda Gummlich; Julia Liep; Carsten Stephan; Ergin Kilic; Klaus Jung; Jean-Noel Billaud; Hellmuth-Alexander Meyer
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

8.  Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.

Authors:  Miao Deng; Jianguang Wang; Yanbin Chen; Like Zhang; Gangqiang Xie; Qipeng Liu; Ting Zhang; Pengfei Yuan; Dechun Liu
Journal:  Mol Med Rep       Date:  2016-06-14       Impact factor: 2.952

9.  Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma.

Authors:  Chao Fan; Lu Chen; Qingling Huang; Tao Shen; Eric A Welsh; Jamie K Teer; Jianfeng Cai; W Douglas Cress; Jie Wu
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.